SCHEMBL5283455

SCHEMBL5283455

CCc1s/c(=N\N=C(C)C)n(C)c1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.35
ALDH1A1 P00352 4/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.34
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
F13A1 P00488 1/20 0.31
GAA P10253 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283459 1.00 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5281141 0.81 NPC1 (0.51) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5298274 0.81 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5298282 0.81 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL4614670 0.80 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL4614674 0.80 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5283048 0.77 MAPT (0.39) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5283041 0.77 MAPT (0.39) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5282485 0.76 ALOX5 (0.39) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL5280145 0.75 CA1 (0.37) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT SMN1; SMN2 3523/4885ALDH1A1 454/4885NPC1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.